Renaissance Technologies
DGX icon

Renaissance Technologies’s Quest Diagnostics DGX Stock Holding History

Renaissance Technologies’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-38,100
Closed -$5.92M – 3644
2024
Q3 		$5.92M Sell
38,100
-46,000
-55% -$6.87M 0.01% 1332
2024
Q2 		$11.5M Sell
84,100
-114,763
-58% -$15.7M 0.02% 845
2024
Q1 		$26.5M Sell
198,863
-288,600
-59% -$37.4M 0.04% 512
2023
Q4 		$67.2M Sell
487,463
-50,200
-9% -$6.6M 0.1% 232
2023
Q3 		$65.5M Sell
537,663
-99,937
-16% -$13.3M 0.11% 188
2023
Q2 		$89.6M Sell
637,600
-33,800
-5% -$4.66M 0.13% 176
2023
Q1 		$95M Sell
671,400
-296,500
-31% -$42.4M 0.13% 189
2022
Q4 		$151M Buy
967,900
+96,000
+11% +$13.8M 0.21% 94
2022
Q3 		$107M Sell
871,900
-249,400
-22% -$32.8M 0.15% 145
2022
Q2 		$149M Sell
1,121,300
-10,600
-0.9% -$1.44M 0.18% 113
2022
Q1 		$155M Sell
1,131,900
-185,800
-14% -$25.9M 0.18% 109
2021
Q4 		$228M Buy
1,317,700
+350,400
+36% +$53.3M 0.28% 64
2021
Q3 		$141M Buy
967,300
+779,000
+414% +$114M 0.18% 112
2021
Q2 		$24.9M Sell
188,300
-80,400
-30% -$10.5M 0.03% 623
2021
Q1 		$34.5M Sell
268,700
-354,100
-57% -$43.6M 0.04% 500
2020
Q4 		$74.2M Buy
622,800
+562,100
+926% +$68.5M 0.08% 251
2020
Q3 		$6.95M Buy
+60,700
New +$7.17M 0.01% 1377
2020
Q2 		– Sell
-157,700
Closed -$12.7M – 3497
2020
Q1 		$12.7M Buy
157,700
+26,400
+20% +$2.73M 0.01% 1011
2019
Q4 		$14M Buy
131,300
+35,000
+36% +$3.65M 0.01% 1218
2019
Q3 		$10.3M Buy
+96,300
New +$9.89M 0.01% 1375
2019
Q2 		– Sell
-25,720
Closed -$2.31M – 3581
2019
Q1 		$2.31M Sell
25,720
-23,100
-47% -$2M ﹤0.01% 2239
2018
Q4 		$4.07M Sell
48,820
-210,580
-81% -$19.7M ﹤0.01% 1850
2018
Q3 		$28M Buy
259,400
+7,900
+3% +$866K 0.03% 721
2018
Q2 		$27.6M Sell
251,500
-88,300
-26% -$9.2M 0.03% 740
2018
Q1 		$34.1M Sell
339,800
-525,400
-61% -$53.8M 0.04% 615
2017
Q4 		$85.2M Buy
865,200
+146,100
+20% +$13.9M 0.09% 240
2017
Q3 		$67.3M Buy
719,100
+283,800
+65% +$30.1M 0.08% 307
2017
Q2 		$48.4M Sell
435,300
-68,400
-14% -$7.23M 0.06% 389
2017
Q1 		$49.5M Buy
503,700
+444,800
+755% +$42.4M 0.07% 356
2016
Q4 		$5.41M Buy
+58,900
New +$5.08M 0.01% 1605
2015
Q4 		– Sell
-107,620
Closed -$6.62M – 3305
2015
Q3 		$6.62M Buy
107,620
+53,420
+99% +$3.73M 0.02% 1188
2015
Q2 		$3.93M Sell
54,200
-529,900
-91% -$39.1M 0.01% 1602
2015
Q1 		$44.9M Sell
584,100
-266,600
-31% -$19.1M 0.1% 255
2014
Q4 		$57M Buy
+850,700
New +$53.7M 0.14% 146
2013
Q4 		– Sell
-127,700
Closed -$7.89M – 2882
2013
Q3 		$7.89M Sell
127,700
-290,800
-69% -$17.4M 0.02% 919
2013
Q2 		$25.4M Buy
+418,500
New +$24.9M 0.07% 352

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies's DGX Position: Q4 2024 in Review

Renaissance Technologies sold out of Quest Diagnostics (DGX) in Q4 2024, closing a stake of 38,100 shares — an estimated $5.92M sold.

Renaissance Technologies first reported a position in DGX in Q2 2013 and held it in 36 quarters. The position peaked at $228M in Q4 2021. 895 funds tracked by Wall St. Rank hold DGX as of Q4 2024.

  • Renaissance Technologies reported no remaining Quest Diagnostics position as of Q4 2024 after selling out during the quarter.
  • Renaissance Technologies sold 38,100 Quest Diagnostics shares in Q4 2024, an estimated $5.92M.
  • Renaissance Technologies first reported a position in Quest Diagnostics in Q2 2013 and held it in 36 quarters.
  • Renaissance Technologies's Quest Diagnostics position peaked at $228M in Q4 2021.
  • 895 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2024.

Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.